CS055 (Chidamide/HBI-8000), a novel histone deacetylase inhibitor, induces G1arrest, ROS-dependent apoptosis and differentiation in human leukaemia cells
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CS055 (Chidamide/HBI-8000), a novel histone deacetylase inhibitor, induces G1arrest, ROS-dependent apoptosis and differentiation in human leukaemia cells
Authors
Keywords
-
Journal
BIOCHEMICAL JOURNAL
Volume 443, Issue 3, Pages 735-746
Publisher
Portland Press Ltd.
Online
2012-02-20
DOI
10.1042/bj20111685
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Regulation of mitochondrial metabolism: yet another facet in the biology of the oncoprotein Bcl-2
- (2011) Shefali Krishna et al. BIOCHEMICAL JOURNAL
- FLIPLinduces caspase 8 activity in the absence of interdomain caspase 8 cleavage and alters substrate specificity
- (2011) Cristina Pop et al. BIOCHEMICAL JOURNAL
- Chidamide (CS055/HBI-8000): a new histone deacetylase inhibitor of the benzamide class with antitumor activity and the ability to enhance immune cell-mediated tumor cell cytotoxicity
- (2011) Zhi-Qiang Ning et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Vorinostat-Induced Apoptosis in Mantle Cell Lymphoma Is Mediated by Acetylation of Proapoptotic BH3-Only Gene Promoters
- (2011) S. Xargay-Torrent et al. CLINICAL CANCER RESEARCH
- Combination of arsenic trioxide and BCNU synergistically triggers redox-mediated autophagic cell death in human solid tumors
- (2011) Ching-Chuan Kuo et al. FREE RADICAL BIOLOGY AND MEDICINE
- CUDC-101, a Multitargeted Inhibitor of Histone Deacetylase, Epidermal Growth Factor Receptor, and Human Epidermal Growth Factor Receptor 2, Exerts Potent Anticancer Activity
- (2010) Cheng-Jung Lai et al. CANCER RESEARCH
- p22phox-dependent NADPH oxidase activity is required for megakaryocytic differentiation
- (2010) J L Sardina et al. CELL DEATH AND DIFFERENTIATION
- Carbonyl reductase 1 protects pancreatic β-cells against oxidative stress-induced apoptosis in glucotoxicity and glucolipotoxicity
- (2010) M.A. Rashid et al. FREE RADICAL BIOLOGY AND MEDICINE
- Histone Deacetylase Inhibitors Activate NF-κB in Human Leukemia Cells through an ATM/NEMO-related Pathway
- (2010) Roberto R. Rosato et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Enhanced Antitumor Activity Induced by Adoptive T-Cell Transfer and Adjunctive Use of the Histone Deacetylase Inhibitor LAQ824
- (2009) D. D. Vo et al. CANCER RESEARCH
- HDAC Inhibitor SNDX-275 Induces Apoptosis in erbB2-Overexpressing Breast Cancer Cells via Down-regulation of erbB3 Expression
- (2009) X. Huang et al. CANCER RESEARCH
- Phase I Study of Vorinostat in Combination with Bortezomib for Relapsed and Refractory Multiple Myeloma
- (2009) A. Badros et al. CLINICAL CANCER RESEARCH
- Bcl-2 Inhibitors: Targeting Mitochondrial Apoptotic Pathways in Cancer Therapy
- (2009) M. H. Kang et al. CLINICAL CANCER RESEARCH
- Histone deacetylase inhibitors: Potential in cancer therapy
- (2009) P.A. Marks et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Suberoylanilide hydroxamic acid sensitizes human oral cancer cells to TRAIL-induced apoptosis through increase DR5 expression
- (2009) C.-C. Yeh et al. MOLECULAR CANCER THERAPEUTICS
- The HDAC inhibitor panobinostat (LBH589) inhibits mesothelioma and lung cancer cells in vitro and in vivo with particular efficacy for small cell lung cancer
- (2009) M. C. Crisanti et al. MOLECULAR CANCER THERAPEUTICS
- Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
- (2009) Dunyaporn Trachootham et al. NATURE REVIEWS DRUG DISCOVERY
- An HDAC inhibitor, trichostatin A, induces a delay at G2/M transition, slippage of spindle checkpoint, and cell death in a transcription-dependent manner
- (2008) Eun Joo Noh et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The novel histone deacetylase inhibitor, LBH589, induces expression of DNA damage response genes and apoptosis in Ph- acute lymphoblastic leukemia cells
- (2008) A. Scuto et al. BLOOD
- Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline chemotherapy: characteristics, outcome, and prognostic factors
- (2008) P. Montesinos et al. BLOOD
- Histone deacetylase inhibitors: Mechanisms of cell death and promise in combination cancer therapy
- (2008) Jennifer S. Carew et al. CANCER LETTERS
- Differential gene expression patterns coupled to commitment and acquisition of phenotypic hallmarks during neutrophil differentiation of human leukaemia HL-60 cells
- (2008) Faustino Mollinedo et al. GENE
- Role of catalase in monocytic differentiation of U937 cells by TPA: hydrogen peroxide as a second messenger
- (2008) T Yamamoto et al. LEUKEMIA
- Blockade of mTOR signaling potentiates the ability of histone deacetylase inhibitor to induce growth arrest and differentiation of acute myelogenous leukemia cells
- (2008) C Nishioka et al. LEUKEMIA
- Cytochrome c: functions beyond respiration
- (2008) Yong-Ling P. Ow et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Mechanism of apoptosis induction by inhibition of the anti-apoptotic BCL-2 proteins
- (2008) J. E. Chipuk et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- How do BCL-2 proteins induce mitochondrial outer membrane permeabilization?
- (2008) Jerry E. Chipuk et al. TRENDS IN CELL BIOLOGY
- The BCL-2 protein family: opposing activities that mediate cell death
- (2007) Richard J. Youle et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started